Compare Iron Mountain Inc (IRM) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iron Mountain Inc vs Novo Nordisk A/S — how do they compare? Iron Mountain Inc trades at $122.41 (market cap $36.44B), while Novo Nordisk A/S trades at $45.95 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 5.7× Iron Mountain Inc's market cap, and Novo Nordisk A/S pays the higher dividend (3.81%). Which is the better fit depends on your goals.
| IRM | NVO | |
|---|---|---|
Market Cap | $36.44B | $207.85B |
Sector | Real Estate | Health |
52-Week High | $133.06 | $63.98 |
52-Week Low | $78.86 | $35.29 |
Enterprise Value | $55.85B | $222.55B |
Dividend Yield | 2.82% | 3.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Iron Mountain Inc
Iron Mountain Inc is a record management services provider. The firm is organized as a REIT. Most of its revenue comes from its storage business, with the rest coming from value-added services. The firm primarily caters to enterprise clients in developed markets. Its business segments include Global RIM Business
Read more on IRM →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
